e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design.
about
'RE:fine drugs': an interactive dashboard to access drug repurposing opportunitiesEmerging role of bioinformatics tools and software in evolution of clinical researchDrugCentral: online drug compendiumIn Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer DrugA survey of current trends in computational drug repositioningPrivileged Structures Revisited.Discovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction.Drug repurposing from the perspective of pharmaceutical companies.Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance.Advances in the design of a multipurpose fragment screening library.Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex.FAF-Drugs3: a web server for compound property calculation and chemical library design.Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors.WITHDRAWN--a resource for withdrawn and discontinued drugsImprovements, trends, and new ideas in molecular docking: 2012-2013 in review.A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds.Comprehensive Network Map of ADME-Tox Databases.Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitorsIn silico model of the human ClC-Kb chloride channel: pore mapping, biostructural pathology and drug screening.Unveiling some FDA-approved drugs as inhibitors of the store-operated Ca2+ entry pathway.An exploration of the 3D chemical space has highlighted a specific shape profile for the compounds intended to inhibit protein-protein interactions.SuperDRUG2: a one stop resource for approved/marketed drugs.Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors.Changing Trends in Computational Drug Repositioning.Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets
P2860
Q24745976-4E21C9BA-662B-4CFA-AA47-6D35B0461FB5Q26741869-8B902A7D-E9B6-4CC4-87B8-3805667BA355Q27697588-C545E2C2-98DF-492B-AE3F-473AAB9D7453Q28546330-81B200B6-452A-460B-840B-B09BD94D5ADFQ28602324-4BEEBB17-D927-49E0-9792-BAFC66105515Q30101030-E314C82B-A772-48CA-965B-007EB6385FA2Q30396236-56E316DE-958D-4E2C-A528-7DAE3EC56F11Q30400634-616F27FB-7D25-454A-B952-4FB18D77A0FFQ33834795-F79CBCB5-2BE3-4AA7-91F6-BE15C0B2CB5DQ34616596-4EC0FA07-62AD-444B-B0E9-90BA092FCA63Q35589799-530FC609-9532-48E1-A4FB-A5FDAAA5E21FQ35604907-3CF602D5-A08B-418B-9E37-03D009C1CE02Q35976167-A9B5B0CA-8590-4023-B64E-31591D80712CQ36434790-9B5934C3-9C91-4B03-A74C-251CD934BE43Q38390892-D760248C-7706-4C72-82C7-8DBED06F0E1EQ38658125-589685B7-448F-4794-8098-C2B428E254AAQ38703101-798241B0-2223-4E8D-9611-491898BC263DQ38732067-32037915-948F-4A14-B363-BDBC26956ED0Q41243043-15D982D9-FCC0-48E0-9F26-8E64FF77378BQ42378965-60684613-7059-4A7C-B274-2C9C13A5C9EEQ46815143-CA4C43D8-C5F1-40A5-8BCC-D5E93FDE658FQ47142191-F8CF8C25-3C57-49B2-B941-01255E7759E3Q48260352-542BEAF0-E44E-4A23-BFA6-D2E7EE0E4BB5Q55717464-AD51427C-7173-4F45-9F66-57DEC92040B2Q58767948-E8838B8B-3A9E-47BA-8046-2C98F76A16BF
P2860
e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
e-Drug3D: 3D structure collect ...... nd fragment-based drug design.
@en
e-Drug3D: 3D structure collect ...... nd fragment-based drug design.
@nl
type
label
e-Drug3D: 3D structure collect ...... nd fragment-based drug design.
@en
e-Drug3D: 3D structure collect ...... nd fragment-based drug design.
@nl
prefLabel
e-Drug3D: 3D structure collect ...... nd fragment-based drug design.
@en
e-Drug3D: 3D structure collect ...... nd fragment-based drug design.
@nl
P2093
P2860
P356
P1433
P1476
e-Drug3D: 3D structure collect ...... and fragment-based drug design
@en
P2093
Dominique Douguet
Emilie Pihan
Lionel Colliandre
P2860
P304
P356
10.1093/BIOINFORMATICS/BTS186
P407
P577
2012-04-26T00:00:00Z